Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.

PLoS One · 2007 · PMC2034536 · PMID 17957238

Europe PMC DOI

hedged sentence

0.0050

closest p · 0.1× alpha

0.0050

boldest claim

The sentences

highly significantp = 0.005actually significant

Cellular immune responses induced by the different vaccination regimens: (a) Short interval BCG-MVA85A When subjects who had been vaccinated 4 weeks previously with BCG were vaccinated with MVA85A, a highly significant rise in antigen specific T cells was seen, 1 week after MVA85A vaccination (PPD, antigen 85 and summed peptide pools, p = 0.005).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.